Segment Information by Division

January 1 to December 31

 Download XLS

 

 

 

€ million

 

Silicones

 

Polymers

 

Bio­solutions

 

Polysilicon

 

Siltronic

 

Other

 

Conso­lidation

 

Group

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

Intangible assets; property, plant and equipment; investment property

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 20.

2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

External sales

 

2,001.0

 

1,176.4

 

206.4

 

1,008.7

 

928.3

 

83.4

 

 

5,404.2

Internal sales

 

0.1

 

18.4

 

 

86.8

 

5.1

 

79.2

 

-189.6

 

Total sales

 

2,001.1

 

1,194.8

 

206.4

 

1,095.5

 

933.4

 

162.6

 

-189.6

 

5,404.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

280.8

 

223.7

 

25.7

 

-117.1

 

28.7

 

-76.0

 

0.4

 

366.2

Depreciation and impairments, and write-ups

 

80.4

 

37.3

 

11.3

 

403.0

 

117.2

 

86.2

 

-0.2

 

735.2

EBITDA

 

361.2

 

261.0

 

37.0

 

285.9

 

145.9

 

10.2

 

0.2

 

1,101.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT includes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Impairment of fixed assets

 

 

 

 

-2.5

 

-0.9

 

 

 

-3.4

Result from investments in joint ventures and associates

 

0.2

 

 

 

 

 

 

 

0.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset additions1

 

88.6

 

37.5

 

9.1

 

130.0

 

89.5

 

72.9

 

 

427.6

Change in the scope of consolidation

 

26.1

 

 

11.2

 

 

 

 

 

37.3

Total asset additions

 

114.7

 

37.5

 

20.3

 

130.0

 

89.5

 

72.9

 

 

464.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets (Dec. 31)

 

1,379.8

 

580.2

 

151.9

 

3,018.1

 

1,034.4

 

1,326.9

 

-29.7

 

7,461.6

Liabilities (Dec. 31)

 

851.8

 

291.2

 

70.9

 

1,168.1

 

631.4

 

1,879.5

 

-24.5

 

4,868.4

Net assets (Dec. 31)

 

528.0

 

289.0

 

81.0

 

1,850.0

 

403.0

 

-552.6

 

-5.2

 

2,593.2

Investments in joint ventures and associates included in net assets (Dec. 31)

 

11.2

 

 

 

 

 

 

 

11.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses

 

37.9

 

17.5

 

6.2

 

16.9

 

66.5

 

41.4

 

-3.0

 

183.4

Employees (Dec. 31)

 

4,566

 

1,484

 

510

 

2,490

 

3,757

 

4,398

 

 

17,205

Employees (average)

 

4,468

 

1,480

 

508

 

2,448

 

3,811

 

4,403

 

 

17,118

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

External sales

 

1,942.8

 

1,162.5

 

197.1

 

978.9

 

923.8

 

91.1

 

 

5,296.2

Internal sales

 

0.5

 

23.0

 

 

84.7

 

7.5

 

106.4

 

-222.1

 

Total sales

 

1,943.3

 

1,185.5

 

197.1

 

1,063.6

 

931.3

 

197.5

 

-222.1

 

5,296.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

194.5

 

184.4

 

21.0

 

162.6

 

4.5

 

-94.5

 

0.9

 

473.4

Depreciation and impairments, and write-ups

 

81.7

 

37.8

 

11.2

 

239.8

 

119.5

 

85.6

 

-0.2

 

575.4

EBITDA

 

276.2

 

222.2

 

32.2

 

402.4

 

124.0

 

-8.9

 

0.7

 

1,048.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT includes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from investments in joint ventures and associates

 

3.3

 

 

 

 

 

 

 

3.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset additions1

 

82.0

 

47.4

 

6.2

 

581.8

 

75.1

 

41.5

 

 

834.0

Asset additions

 

82.0

 

47.4

 

6.2

 

581.8

 

75.1

 

41.5

 

 

834.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets (Dec. 31)

 

1,309.3

 

589.9

 

149.3

 

3,132.0

 

1,016.1

 

1,096.3

 

-28.5

 

7,264.4

Liabilities (Dec. 31)

 

749.0

 

281.1

 

67.0

 

1,392.0

 

543.5

 

1,451.5

 

-14.8

 

4,469.3

Net assets (Dec. 31)

 

560.3

 

308.8

 

82.3

 

1,740.0

 

472.6

 

-355.2

 

-13.7

 

2,795.1

Investments in joint ventures and associates included in net assets (Dec. 31)

 

21.2

 

 

 

 

 

 

 

21.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses

 

35.8

 

14.8

 

6.1

 

15.3

 

64.3

 

42.8

 

-3.8

 

175.3

Employees (Dec. 31)

 

4,353

 

1,461

 

491

 

2,373

 

3,894

 

4,400

 

 

16,972

Employees (average)

 

4,348

 

1,442

 

491

 

2,278

 

4,004

 

4,374

 

 

16,937